NCT06004011 AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
| NCT ID | NCT06004011 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Implenomics |
| Condition | Cervical Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 4,100 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 4,100 participants in total. It began in 2024-05-01 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Adolescents and young adults living with HIV experience higher premature mortality from cancer than their uninfected peers. In Zambia, because of multilevel barriers, interventions for early diagnosis and optimized treatment to reduce this cancer mortality are underutilized for this disproportionally impacted cohort. In this study, the investigators will test peer-to-peer education and support strategies to increase use of early diagnosis services in HIV treatment facilities and improve compliance with cancer treatment in the cancer center.
Eligibility Criteria
Inclusion Criteria: * 15 to 39 years of age at the time of study enrolment, on antiretroviral medication (ART) for at least 6 months and with no pending plans to move from current residence during the 3-year study duration Exclusion Criteria: * pregnant at study enrolment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06004011 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 39 Years, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06004011 currently recruiting?
Yes, NCT06004011 is actively recruiting participants. Contact the research team at sujha.subramanian@implenomics.com for enrollment information.
Where is the NCT06004011 trial being conducted?
This trial is being conducted at Lusaka, Zambia.
Who is sponsoring the NCT06004011 clinical trial?
NCT06004011 is sponsored by Implenomics. The trial plans to enroll 4,100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.